25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Accolade Inc
Buy, Hold or Sell?

Let's analyze Accolade together

I guess you are interested in Accolade Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Accolade Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Accolade Inc

I send you an email if I find something interesting about Accolade Inc.

1. Quick Overview

1.1. Quick analysis of Accolade (30 sec.)










1.2. What can you expect buying and holding a share of Accolade? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.83
Expected worth in 1 year
$2.34
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-1.49
Return On Investment
-21.6%

For what price can you sell your share?

Current Price per Share
$6.90
Expected price per share
$4.55 - $8.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Accolade (5 min.)




Live pricePrice per Share (EOD)
$6.90
Intrinsic Value Per Share
$5.48 - $6.77
Total Value Per Share
$9.32 - $10.61

2.2. Growth of Accolade (5 min.)




Is Accolade growing?

Current yearPrevious yearGrowGrow %
How rich?$313m$450m-$45.8m-11.4%

How much money is Accolade making?

Current yearPrevious yearGrowGrow %
Making money-$45m-$30.6m-$14.3m-31.9%
Net Profit Margin-42.2%-31.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Accolade (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#26 / 104

Most Revenue
#24 / 104

Most Profit
#96 / 104
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Accolade?

Welcome investor! Accolade's management wants to use your money to grow the business. In return you get a share of Accolade.

First you should know what it really means to hold a share of Accolade. And how you can make/lose money.

Speculation

The Price per Share of Accolade is $6.9. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Accolade.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Accolade, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.83. Based on the TTM, the Book Value Change Per Share is $-0.37 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Accolade.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.48-21.5%-0.55-8.0%-0.36-5.2%-0.55-8.0%-0.49-7.1%
Usd Book Value Change Per Share-1.35-19.5%-0.37-5.4%-0.16-2.3%0.355.1%0.162.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.35-19.5%-0.37-5.4%-0.16-2.3%0.355.1%0.162.3%
Usd Price Per Share3.86-6.38-11.34-18.38-15.32-
Price to Earnings Ratio-0.65--9.37--7.95--20.13--16.78-
Price-to-Total Gains Ratio-2.86--2.68--108.79-60.60-60.60-
Price to Book Ratio1.01-1.26-2.06-3.55-2.96-
Price-to-Total Gains Ratio-2.86--2.68--108.79-60.60-60.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.9
Number of shares144
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.370.35
Usd Total Gains Per Share-0.370.35
Gains per Quarter (144 shares)-53.6550.85
Gains per Year (144 shares)-214.59203.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-215-2250203193
20-429-4400407396
30-644-6550610599
40-858-8700814802
50-1073-1085010171005
60-1288-1300012211208
70-1502-1515014241411
80-1717-1730016271614
90-1931-1945018311817
100-2146-2160020342020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.023.00.04.2%1.023.00.04.2%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%9.011.00.045.0%9.013.02.037.5%9.013.02.037.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%9.011.00.045.0%9.013.02.037.5%9.013.02.037.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Accolade Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.348-0.373-72%-0.157-88%0.353-482%0.160-944%
Book Value Per Share--3.8324.949-23%5.510-30%5.167-26%3.818+0%
Current Ratio--2.6302.676-2%2.898-9%3.050-14%2.603+1%
Debt To Asset Ratio--0.5170.456+13%0.473+9%0.587-12%1.254-59%
Debt To Equity Ratio--1.0690.847+26%0.898+19%0.658+62%0.548+95%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--206308168.000417630691.000-51%808421039.000-74%1630946054.000-87%1630946054.000-87%
Eps---1.485-0.552-63%-0.359-76%-0.553-63%-0.489-67%
Ev To Ebitda Ratio---3.2639.897-133%-8.729+168%-34.421+955%-34.421+955%
Ev To Sales Ratio--0.4910.909-46%2.087-76%6.827-93%6.827-93%
Free Cash Flow Per Share---0.095-0.030-68%-0.115+21%-0.119+26%-0.112+18%
Free Cash Flow To Equity Per Share---0.081-0.011-86%-0.293+261%0.273-130%0.227-136%
Gross Profit Margin--1.2102.392-49%1.851-35%1.867-35%1.819-33%
Intrinsic Value_10Y_max--6.774--------
Intrinsic Value_10Y_min--5.483--------
Intrinsic Value_1Y_max---0.228--------
Intrinsic Value_1Y_min---0.224--------
Intrinsic Value_3Y_max--0.007--------
Intrinsic Value_3Y_min---0.008--------
Intrinsic Value_5Y_max--1.074--------
Intrinsic Value_5Y_min--0.937--------
Market Cap563583720.000+44%315280168.000521314941.000-40%926441789.000-66%1501623898.600-79%1251353248.833-75%
Net Profit Margin---1.154-0.422-63%-0.318-72%-0.554-52%-0.539-53%
Operating Margin---0.246-0.205-17%-0.358+46%-0.364+48%-0.377+53%
Operating Ratio--2.1641.432+51%1.268+71%1.391+56%1.400+55%
Pb Ratio1.801+44%1.0071.263-20%2.060-51%3.548-72%2.956-66%
Pe Ratio-1.162-79%-0.650-9.368+1341%-7.950+1123%-20.134+2998%-16.778+2481%
Price Per Share6.900+44%3.8606.383-40%11.343-66%18.385-79%15.320-75%
Price To Free Cash Flow Ratio-18.140-79%-10.14814.251-171%9.650-205%-13.864+37%-11.554+14%
Price To Total Gains Ratio-5.120-79%-2.864-2.682-6%-108.789+3698%60.599-105%60.599-105%
Quick Ratio--2.8553.002-5%2.739+4%3.038-6%2.586+10%
Return On Assets---0.187-0.066-65%-0.036-81%-0.061-68%-0.086-54%
Return On Equity---0.387-0.131-66%-0.068-82%-0.098-75%-0.081-79%
Total Gains Per Share---1.348-0.373-72%-0.157-88%0.353-482%0.160-944%
Usd Book Value--313000000.000404201000.000-23%450081750.000-30%422001750.000-26%311844166.667+0%
Usd Book Value Change Per Share---1.348-0.373-72%-0.157-88%0.353-482%0.160-944%
Usd Book Value Per Share--3.8324.949-23%5.510-30%5.167-26%3.818+0%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--206308168.000417630691.000-51%808421039.000-74%1630946054.000-87%1630946054.000-87%
Usd Eps---1.485-0.552-63%-0.359-76%-0.553-63%-0.489-67%
Usd Free Cash Flow---7767000.000-2475750.000-68%-9366750.000+21%-9750250.000+26%-9185916.667+18%
Usd Free Cash Flow Per Share---0.095-0.030-68%-0.115+21%-0.119+26%-0.112+18%
Usd Free Cash Flow To Equity Per Share---0.081-0.011-86%-0.293+261%0.273-130%0.227-136%
Usd Market Cap563583720.000+44%315280168.000521314941.000-40%926441789.000-66%1501623898.600-79%1251353248.833-75%
Usd Price Per Share6.900+44%3.8606.383-40%11.343-66%18.385-79%15.320-75%
Usd Profit---121264000.000-45074250.000-63%-30682750.000-75%-45408000.000-63%-40180625.000-67%
Usd Revenue--105061000.000111679500.000-6%97121500.000+8%81207050.000+29%72804041.667+44%
Usd Total Gains Per Share---1.348-0.373-72%-0.157-88%0.353-482%0.160-944%
 EOD+5 -3MRQTTM+3 -35YOY+13 -255Y+9 -2910Y+14 -24

3.3 Fundamental Score

Let's check the fundamental score of Accolade Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.162
Price to Book Ratio (EOD)Between0-11.801
Net Profit Margin (MRQ)Greater than0-1.154
Operating Margin (MRQ)Greater than0-0.246
Quick Ratio (MRQ)Greater than12.855
Current Ratio (MRQ)Greater than12.630
Debt to Asset Ratio (MRQ)Less than10.517
Debt to Equity Ratio (MRQ)Less than11.069
Return on Equity (MRQ)Greater than0.15-0.387
Return on Assets (MRQ)Greater than0.05-0.187
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Accolade Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5082.132
Ma 20Greater thanMa 506.892
Ma 50Greater thanMa 1005.253
Ma 100Greater thanMa 2004.431
OpenGreater thanClose6.900
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2025-02-06 09:58:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Accolade earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Accolade to the Health Information Services industry mean.
  • A Net Profit Margin of -115.4% means that $-1.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Accolade Inc:

  • The MRQ is -115.4%. The company is making a huge loss. -2
  • The TTM is -42.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-115.4%TTM-42.2%-73.2%
TTM-42.2%YOY-31.8%-10.5%
TTM-42.2%5Y-55.4%+13.1%
5Y-55.4%10Y-53.9%-1.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-115.4%-13.0%-102.4%
TTM-42.2%-18.9%-23.3%
YOY-31.8%-16.7%-15.1%
5Y-55.4%-26.9%-28.5%
10Y-53.9%-33.9%-20.0%
4.3.1.2. Return on Assets

Shows how efficient Accolade is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Accolade to the Health Information Services industry mean.
  • -18.7% Return on Assets means that Accolade generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Accolade Inc:

  • The MRQ is -18.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.7%TTM-6.6%-12.1%
TTM-6.6%YOY-3.6%-3.0%
TTM-6.6%5Y-6.1%-0.5%
5Y-6.1%10Y-8.6%+2.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.7%-3.8%-14.9%
TTM-6.6%-5.3%-1.3%
YOY-3.6%-4.9%+1.3%
5Y-6.1%-5.2%-0.9%
10Y-8.6%-6.3%-2.3%
4.3.1.3. Return on Equity

Shows how efficient Accolade is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Accolade to the Health Information Services industry mean.
  • -38.7% Return on Equity means Accolade generated $-0.39 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Accolade Inc:

  • The MRQ is -38.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.7%TTM-13.1%-25.6%
TTM-13.1%YOY-6.8%-6.3%
TTM-13.1%5Y-9.8%-3.3%
5Y-9.8%10Y-8.1%-1.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.7%-2.2%-36.5%
TTM-13.1%-5.3%-7.8%
YOY-6.8%-5.4%-1.4%
5Y-9.8%-8.1%-1.7%
10Y-8.1%-8.5%+0.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Accolade Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Accolade is operating .

  • Measures how much profit Accolade makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Accolade to the Health Information Services industry mean.
  • An Operating Margin of -24.6% means the company generated $-0.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Accolade Inc:

  • The MRQ is -24.6%. The company is operating very inefficient. -2
  • The TTM is -20.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24.6%TTM-20.5%-4.1%
TTM-20.5%YOY-35.8%+15.3%
TTM-20.5%5Y-36.4%+15.9%
5Y-36.4%10Y-37.7%+1.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.6%-21.8%-2.8%
TTM-20.5%-20.5%0.0%
YOY-35.8%-9.1%-26.7%
5Y-36.4%-16.9%-19.5%
10Y-37.7%-27.7%-10.0%
4.3.2.2. Operating Ratio

Measures how efficient Accolade is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 2.16 means that the operating costs are $2.16 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Accolade Inc:

  • The MRQ is 2.164. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.432. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.164TTM1.432+0.732
TTM1.432YOY1.268+0.164
TTM1.4325Y1.391+0.041
5Y1.39110Y1.400-0.009
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1641.270+0.894
TTM1.4321.321+0.111
YOY1.2681.348-0.080
5Y1.3911.315+0.076
10Y1.4001.324+0.076
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Accolade Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Accolade is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 2.63 means the company has $2.63 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Accolade Inc:

  • The MRQ is 2.630. The company is able to pay all its short-term debts. +1
  • The TTM is 2.676. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.630TTM2.676-0.046
TTM2.676YOY2.898-0.222
TTM2.6765Y3.050-0.374
5Y3.05010Y2.603+0.447
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6301.694+0.936
TTM2.6761.660+1.016
YOY2.8981.813+1.085
5Y3.0502.528+0.522
10Y2.6032.331+0.272
4.4.3.2. Quick Ratio

Measures if Accolade is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Accolade to the Health Information Services industry mean.
  • A Quick Ratio of 2.86 means the company can pay off $2.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Accolade Inc:

  • The MRQ is 2.855. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.002. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.855TTM3.002-0.147
TTM3.002YOY2.739+0.264
TTM3.0025Y3.038-0.036
5Y3.03810Y2.586+0.452
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8551.177+1.678
TTM3.0021.239+1.763
YOY2.7391.362+1.377
5Y3.0382.093+0.945
10Y2.5862.264+0.322
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Accolade Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Accolade assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Accolade to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.52 means that Accolade assets are financed with 51.7% credit (debt) and the remaining percentage (100% - 51.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Accolade Inc:

  • The MRQ is 0.517. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.456. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.517TTM0.456+0.060
TTM0.456YOY0.473-0.017
TTM0.4565Y0.587-0.131
5Y0.58710Y1.254-0.667
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5170.422+0.095
TTM0.4560.422+0.034
YOY0.4730.432+0.041
5Y0.5870.422+0.165
10Y1.2540.423+0.831
4.5.4.2. Debt to Equity Ratio

Measures if Accolade is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Accolade to the Health Information Services industry mean.
  • A Debt to Equity ratio of 106.9% means that company has $1.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Accolade Inc:

  • The MRQ is 1.069. The company is able to pay all its debts with equity. +1
  • The TTM is 0.847. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.069TTM0.847+0.222
TTM0.847YOY0.898-0.051
TTM0.8475Y0.658+0.189
5Y0.65810Y0.548+0.110
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0690.558+0.511
TTM0.8470.568+0.279
YOY0.8980.629+0.269
5Y0.6580.602+0.056
10Y0.5480.645-0.097
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Accolade generates.

  • Above 15 is considered overpriced but always compare Accolade to the Health Information Services industry mean.
  • A PE ratio of -0.65 means the investor is paying $-0.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Accolade Inc:

  • The EOD is -1.162. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.650. Based on the earnings, the company is expensive. -2
  • The TTM is -9.368. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.162MRQ-0.650-0.512
MRQ-0.650TTM-9.368+8.718
TTM-9.368YOY-7.950-1.419
TTM-9.3685Y-20.134+10.765
5Y-20.13410Y-16.778-3.356
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.162-1.136-0.026
MRQ-0.650-0.825+0.175
TTM-9.368-1.442-7.926
YOY-7.950-2.202-5.748
5Y-20.134-3.388-16.746
10Y-16.778-3.896-12.882
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Accolade Inc:

  • The EOD is -18.140. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.148. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 14.251. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-18.140MRQ-10.148-7.992
MRQ-10.148TTM14.251-24.399
TTM14.251YOY9.650+4.601
TTM14.2515Y-13.864+28.115
5Y-13.86410Y-11.554-2.311
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-18.140-0.801-17.339
MRQ-10.148-0.372-9.776
TTM14.251-1.269+15.520
YOY9.650-3.052+12.702
5Y-13.864-6.794-7.070
10Y-11.554-4.258-7.296
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Accolade is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 1.01 means the investor is paying $1.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Accolade Inc:

  • The EOD is 1.801. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.007. Based on the equity, the company is underpriced. +1
  • The TTM is 1.263. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.801MRQ1.007+0.793
MRQ1.007TTM1.263-0.256
TTM1.263YOY2.060-0.796
TTM1.2635Y3.548-2.284
5Y3.54810Y2.956+0.591
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD1.8011.876-0.075
MRQ1.0071.941-0.934
TTM1.2631.924-0.661
YOY2.0602.229-0.169
5Y3.5484.087-0.539
10Y2.9564.293-1.337
4.6.2. Total Gains per Share

2.4. Latest News of Accolade Inc

Does Accolade Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Accolade Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-04
01:31
Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Accolade Inc.

4.8.1. Institutions holding Accolade Inc

Institutions are holding 82.304% of the shares of Accolade Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30BlackRock Inc7.64070.00056240828821541.334
2024-09-30ARK Investment Management LLC6.58990.18955382533-258915-4.5895
2024-09-30Brown Advisory Holdings Inc5.90690.02334824662-626812-11.498
2024-09-30Vanguard Group Inc5.08960.00034157154360170.874
2024-09-30Millennium Management LLC4.88240.00733987883136468252.0235
2024-09-30Deerfield Management Co4.25450.1999347500000
2024-09-30Prosight Management, LP3.432.65442801598131207388.0867
2024-09-30State Street Corp2.35930.00031927089-54845-2.7672
2024-09-30Nikko Asset Management Americas Inc2.31030.08211887011-124920-6.209
2024-12-31Fairman Group LLC2.20675.075180239966511258.4823
2024-09-30Geode Capital Management, LLC2.18180.00061782038835564.9195
2024-12-31Sumitomo Mitsui Trust Group Inc2.16270.00411766480-123643-6.5415
2024-09-30Clearline Capital LP1.88490.2516153957870879485.3163
2024-09-30Dimensional Fund Advisors, Inc.1.8480.00141509390-144700-8.748
2024-09-30D. E. Shaw & Co LP1.570.00421282360976175318.8187
2024-09-30Whetstone Capital Advisors, LLC1.22171.85159978899978890
2024-09-30Kennedy Capital Management Inc0.92630.06437565567565560
2024-09-30Jane Street Group LLC0.89060.0006727406-277739-27.6317
2024-09-30Bellevue Group AG0.78460.04640865-201712-23.9399
2024-09-30Point72 Asset Management, L.P.0.75610.0066175796175790
Total 58.89710.456948106298+5787301+12.0%

4.9.2. Funds holding Accolade Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31ARK Genomic Revolution5.63461.49464602291-744989-13.9321
2025-01-30ARK Genomic Revolution ETF4.29492.05043508013-102498-2.8389
2024-12-31Vanguard Total Stock Mkt Idx Inv2.70940.0004221302200
2025-01-29iShares Russell 2000 ETF2.38230.0181945855-295-0.0152
2024-12-31Nikko AM ARK Pstv Chg Innovt P JPY Acc1.39140.17951136499-5477-0.4796
2024-12-31Vanguard Institutional Extnd Mkt Idx Tr1.390.0034113533200
2024-12-31Kennedy Micro Cap1.06590.58587062229489251.2205
2024-06-07Nikko Gbl All Biological Genome Eq MF1.02432.5841836635-108665-11.4953
2024-11-30Fidelity Small Cap Index0.85660.0092699626-41871-5.6468
2024-12-31Bellevue (Lux) Bellevue Dgtl Hthl I2 EUR0.75360.7245615509-25356-3.9565
2025-01-29iShares Russell 2000 Value ETF0.54960.025344890500
2024-12-31State St Russell Sm/Mid Cp® Indx NL Cl C0.54050.0033441449-6300-1.407
2024-12-31Fidelity Extended Market Index0.49760.0034406458-3275-0.7993
2025-01-30Schwab US Small-Cap ETF™0.43510.013355368-450-0.1265
2024-12-31Vanguard Russell 2000 ETF0.42290.009134545156681.6681
2024-11-30DFA US Targeted Value I0.41350.008833772200
2024-12-31Vanguard Health Care ETF0.30430.0045248538-2573-1.0246
2025-01-30Dimensional US Targeted Value ETF0.29980.01524483700
2024-12-31State St Russell Sm Cap® Indx SL Cl I0.29340.008623963200
2025-01-29iShares Russell 2000 Growth ETF0.27730.012222650000
Total 25.5377.752320858264-741189-3.6%

5.3. Insider Transactions

Insiders are holding 3.122% of the shares of Accolade Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-02-04Richard EskewSELL3906.93
2025-02-04Robert N CavanaughSELL5576.93
2025-02-04Stephen H BarnesSELL4486.93
2025-02-04Rajeev SinghSELL11706.93
2025-01-17Rajeev SinghSELL3096.86
2025-01-17Robert N CavanaughSELL1866.86
2025-01-17Stephen H BarnesSELL1546.86
2025-01-13Rajeev SinghSELL5416.88
2025-01-13Robert N CavanaughSELL2566.88
2025-01-13Stephen H BarnesSELL2846.88
2025-01-03Colin MchughSELL5243.41
2025-01-03Stephen H BarnesSELL5353.41
2025-01-03Robert N CavanaughSELL5533.41
2025-01-03Richard EskewSELL3933.41
2025-01-03Rajeev SinghSELL11583.41
2024-12-17Rajeev SinghSELL3813.43
2024-12-11Rajeev SinghSELL6673.62
2024-12-11Robert N CavanaughSELL2143.62
2024-12-11Stephen H BarnesSELL2223.62
2024-12-03Colin MchughSELL23883.6
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-11-302024-02-292024-05-312024-08-312024-11-30
Net Debt  11,68144,24955,930-4,04451,88613,60765,493-222,926-157,433



5.2. Latest Balance Sheet

Balance Sheet of 2024-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets647,451
Total Liabilities334,451
Total Stockholder Equity313,000
 As reported
Total Liabilities 334,451
Total Stockholder Equity+ 313,000
Total Assets = 647,451

Assets

Total Assets647,451
Total Current Assets272,446
Long-term Assets375,005
Total Current Assets
Cash And Cash Equivalents 185,922
Short-term Investments 39,557
Net Receivables 30,694
Other Current Assets 16,273
Total Current Assets  (as reported)272,446
Total Current Assets  (calculated)272,446
+/-0
Long-term Assets
Property Plant Equipment 43,244
Goodwill 181,731
Intangible Assets 139,314
Long-term Assets Other 10,716
Long-term Assets  (as reported)375,005
Long-term Assets  (calculated)375,005
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities103,578
Long-term Liabilities230,873
Total Stockholder Equity313,000
Total Current Liabilities
Short-term Debt 14,682
Accounts payable 10,344
Other Current Liabilities 40,292
Total Current Liabilities  (as reported)103,578
Total Current Liabilities  (calculated)65,318
+/- 38,260
Long-term Liabilities
Long term Debt 209,403
Capital Lease Obligations 28,489
Long-term Liabilities Other 256
Long-term Liabilities  (as reported)230,873
Long-term Liabilities  (calculated)238,148
+/- 7,275
Total Stockholder Equity
Common Stock8
Retained Earnings -1,226,889
Accumulated Other Comprehensive Income 24
Other Stockholders Equity 1,539,857
Total Stockholder Equity (as reported)313,000
Total Stockholder Equity (calculated)313,000
+/-0
Other
Capital Stock8
Cash and Short Term Investments 225,479
Common Stock Shares Outstanding 80,647
Current Deferred Revenue38,260
Liabilities and Stockholders Equity 647,451
Net Debt -157,433
Net Invested Capital 522,403
Net Working Capital 168,868
Property Plant and Equipment Gross 43,244
Short Long Term Debt Total 28,489



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-11-302024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-28
> Total Assets 
65,762
0
0
68,877
124,414
120,482
266,877
467,495
475,510
891,492
1,269,794
1,263,352
1,285,529
944,454
931,684
913,791
903,069
875,707
854,320
785,471
788,151
767,369
756,072
647,451
647,451756,072767,369788,151785,471854,320875,707903,069913,791931,684944,4541,285,5291,263,3521,269,794891,492475,510467,495266,877120,482124,41468,8770065,762
   > Total Current Assets 
46,885
0
0
46,207
100,101
96,754
242,837
444,513
453,981
453,457
417,610
407,556
409,137
377,567
374,787
366,231
365,949
348,474
336,261
272,090
280,543
271,007
274,736
272,446
272,446274,736271,007280,543272,090336,261348,474365,949366,231374,787377,567409,137407,556417,610453,457453,981444,513242,83796,754100,10146,2070046,885
       Cash And Cash Equivalents 
42,701
0
0
39,654
84,321
77,682
222,111
418,938
433,884
325,508
384,003
365,982
365,853
335,628
330,633
325,637
321,083
302,870
292,187
230,017
185,718
188,709
173,315
185,922
185,922173,315188,709185,718230,017292,187302,870321,083325,637330,633335,628365,853365,982384,003325,508433,884418,938222,11177,68284,32139,6540042,701
       Short-term Investments 
0
0
0
0
0
0
0
0
0
99,998
0
0
0
0
0
0
0
0
0
0
51,315
41,931
61,035
39,557
39,55761,03541,93151,315000000000099,998000000000
       Net Receivables 
436
0
0
384
1,189
3,205
10,770
16,766
11,837
18,022
18,720
25,903
30,801
28,478
30,608
24,185
26,695
26,299
25,314
25,557
27,702
27,711
25,218
30,694
30,69425,21827,71127,70225,55725,31426,29926,69524,18530,60828,47830,80125,90318,72018,02211,83716,76610,7703,2051,18938400436
       Inventory 
908
0
0
1,465
1,647
1,674
1,942
2,211
2,303
2,494
2,864
2,957
3,015
3,179
0
-3,702
4,022
3,933
4,474
4,462
0
0
10,869
0
010,869004,4624,4743,9334,022-3,70203,1793,0152,9572,8642,4942,3032,2111,9421,6741,6471,46500908
       Other Current Assets 
2,840
0
0
4,704
12,944
14,193
8,014
6,598
5,957
7,435
12,023
12,714
9,468
10,282
13,546
20,111
14,149
15,372
14,286
16,516
31,616
16,908
15,168
16,273
16,27315,16816,90831,61616,51614,28615,37214,14920,11113,54610,2829,46812,71412,0237,4355,9576,5988,01414,19312,9444,704002,840
   > Long-term Assets 
18,877
0
0
22,670
24,313
23,728
24,040
22,982
21,529
438,035
852,184
855,796
876,392
566,887
556,897
547,560
537,120
527,233
518,059
513,381
507,608
496,362
481,336
375,005
375,005481,336496,362507,608513,381518,059527,233537,120547,560556,897566,887876,392855,796852,184438,03521,52922,98224,04023,72824,31322,6700018,877
       Property Plant Equipment 
15,274
0
0
11,811
13,625
12,598
11,728
10,496
9,227
12,157
12,181
11,965
44,923
45,655
44,606
44,497
44,288
44,688
44,440
48,070
47,480
46,766
44,574
43,244
43,24444,57446,76647,48048,07044,44044,68844,28844,49744,60645,65544,92311,96512,18112,1579,22710,49611,72812,59813,62511,8110015,274
       Goodwill 
0
0
0
4,013
4,013
4,013
4,013
4,013
4,013
214,177
575,660
579,581
577,896
278,191
278,191
278,191
278,191
278,191
278,191
278,191
278,191
278,191
278,191
181,731
181,731278,191278,191278,191278,191278,191278,191278,191278,191278,191278,191577,896579,581575,660214,1774,0134,0134,0134,0134,0134,013000
       Intangible Assets 
0
0
0
2,417
2,054
1,692
1,329
967
604
203,498
255,166
255,129
244,690
234,318
223,946
213,574
203,202
192,829
183,689
174,548
165,407
156,524
147,642
139,314
139,314147,642156,524165,407174,548183,689192,829203,202213,574223,946234,318244,690255,129255,166203,4986049671,3291,6922,0542,417000
       Other Assets 
3,603
0
0
4,429
4,621
5,425
6,970
8,473
7,685
8,203
9,177
9,121
8,883
8,723
10,154
11,298
0
0
11,739
0
0
0
0
0
0000011,7390011,29810,1548,7238,8839,1219,1778,2037,6858,4736,9705,4254,6214,429003,603
> Total Liabilities 
296,383
0
0
332,789
148,187
386,979
74,773
79,208
84,662
454,383
536,236
474,652
429,735
409,947
425,370
427,838
429,283
421,529
416,676
350,752
342,686
332,104
332,998
334,451
334,451332,998332,104342,686350,752416,676421,529429,283427,838425,370409,947429,735474,652536,236454,38384,66279,20874,773386,979148,187332,78900296,383
   > Total Current Liabilities 
56,665
0
0
72,913
69,958
75,393
68,935
73,439
79,075
167,487
249,397
184,602
111,753
95,479
112,662
116,616
119,414
112,736
109,003
115,669
107,850
98,442
101,020
103,578
103,578101,02098,442107,850115,669109,003112,736119,414116,616112,66295,479111,753184,602249,397167,48779,07573,43968,93575,39369,95872,9130056,665
       Short-term Debt 
335
0
0
0
512
0
0
0
1,074
34,288
45,685
46,838
6,589
7,016
7,173
7,392
7,284
6,915
6,355
13,800
7,089
14,384
14,136
14,682
14,68214,13614,3847,08913,8006,3556,9157,2847,3927,1737,0166,58946,83845,68534,2881,074000512000335
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
596
0
0
0
596
0
0
0
438
0
0
0
000438000596000596000000000000
       Accounts payable 
2,454
0
0
5,063
5,273
4,940
3,811
4,136
7,390
7,089
8,696
5,744
7,837
7,777
11,094
9,987
10,155
5,461
7,098
12,667
13,749
8,139
9,027
10,344
10,3449,0278,13913,74912,6677,0985,46110,1559,98711,0947,7777,8375,7448,6967,0897,3904,1363,8114,9405,2735,063002,454
       Other Current Liabilities 
22,958
0
0
25,822
30,580
31,731
27,610
31,427
39,717
86,708
145,214
82,584
50,189
32,699
40,871
46,493
51,090
41,410
37,900
36,430
50,510
37,174
37,147
40,292
40,29237,14737,17450,51036,43037,90041,41051,09046,49340,87132,69950,18982,584145,21486,70839,71731,42727,61031,73130,58025,8220022,958
   > Long-term Liabilities 
239,718
0
0
259,876
78,229
311,586
5,838
5,769
5,587
286,896
286,839
290,050
317,982
314,468
312,708
311,222
309,869
308,793
307,673
235,083
234,836
233,662
231,978
230,873
230,873231,978233,662234,836235,083307,673308,793309,869311,222312,708314,468317,982290,050286,839286,8965,5875,7695,838311,58678,229259,87600239,718
       Long term Debt Total 
0
0
0
20,954
0
0
0
0
0
279,434
279,849
280,259
280,666
281,083
281,500
281,914
282,323
0
0
0
0
0
0
0
0000000282,323281,914281,500281,083280,666280,259279,849279,4340000020,954000
       Other Liabilities 
5,854
0
0
5,900
5,919
6,040
5,838
5,769
5,587
7,462
6,990
9,791
4,830
843
487
459
0
0
262
0
0
0
0
0
00000262004594878434,8309,7916,9907,4625,5875,7695,8386,0405,9195,900005,854
       Deferred Long Term Liability 
2,922
0
0
3,942
3,876
4,405
5,840
5,375
5,192
7,014
6,637
9,492
4,562
7,148
8,792
9,981
9,815
0
9,077
0
0
0
0
0
000009,07709,8159,9818,7927,1484,5629,4926,6377,0145,1925,3755,8404,4053,8763,942002,922
> Total Stockholder Equity
-230,621
0
0
-263,912
-23,773
-266,497
192,104
388,287
390,848
437,109
733,558
788,700
855,794
534,507
506,314
485,953
473,786
454,178
437,644
434,719
445,465
435,265
423,074
313,000
313,000423,074435,265445,465434,719437,644454,178473,786485,953506,314534,507855,794788,700733,558437,109390,848388,287192,104-266,497-23,773-263,91200-230,621
   Common Stock
1
0
0
1
4
2
5
5
6
6
7
7
7
7
7
7
7
8
8
8
8
8
8
8
888888877777776655241001
   Retained Earnings -1,226,889-1,105,625-1,081,691-1,054,099-1,046,592-1,025,528-992,703-954,294-923,861-883,989-837,466-494,644-460,088-482,591-420,227-371,520-366,794-350,199-334,828-320,868-318,72900-269,503
   Accumulated Other Comprehensive Income 
-44,955
0
0
0
-50,608
0
-266,877
-467,495
0
0
0
0
0
0
0
0
0
0
0
0
-47
-34
26
24
2426-34-47000000000000-467,495-266,8770-50,608000-44,955
   Capital Surplus 
0
0
0
54,816
0
0
0
755,076
762,362
857,330
1,216,142
1,248,781
1,350,431
1,371,966
1,390,296
1,409,807
1,428,073
0
0
0
0
0
0
0
00000001,428,0731,409,8071,390,2961,371,9661,350,4311,248,7811,216,142857,330762,362755,07600054,816000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
83,836
0
0
54,816
347,699
68,329
542,298
755,076
762,362
857,330
1,216,142
1,248,781
1,350,431
1,371,966
1,390,296
1,409,807
1,428,073
1,446,873
1,463,164
1,481,303
1,499,603
1,516,982
1,528,665
1,539,857
1,539,8571,528,6651,516,9821,499,6031,481,3031,463,1641,446,8731,428,0731,409,8071,390,2961,371,9661,350,4311,248,7811,216,142857,330762,362755,076542,29868,329347,69954,8160083,836



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-02-29. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue414,292
Cost of Revenue-222,232
Gross Profit192,060192,060
 
Operating Income (+$)
Gross Profit192,060
Operating Expense-307,199
Operating Income-114,453-115,139
 
Operating Expense (+$)
Research Development99,159
Selling General Administrative62,124
Selling And Marketing Expenses100,066
Operating Expense307,199261,349
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,952
Other Finance Cost-11,904
Net Interest Income5,952
 
Pretax Income (+$)
Operating Income-114,453
Net Interest Income5,952
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-98,570-130,336
EBIT - interestExpense = -122,309
-98,570
-93,853
Interest Expense5,952
Earnings Before Interest and Taxes (EBIT)-116,357-92,618
Earnings Before Interest and Taxes (EBITDA)-71,193
 
After tax Income (+$)
Income Before Tax-98,570
Tax Provision-1,235
Net Income From Continuing Ops-99,805-99,805
Net Income-99,805
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses528,745
Total Other Income/Expenses Net15,883-5,952
 

Technical Analysis of Accolade
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Accolade. The general trend of Accolade is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Accolade's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Accolade Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 6.95 < 7.02 < 8.05.

The bearish price targets are: 6.855 > 6.41 > 4.55.

Tweet this
Accolade Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Accolade Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Accolade Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Accolade Inc. The current macd is 0.41887404.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Accolade price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Accolade. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Accolade price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Accolade Inc Daily Moving Average Convergence/Divergence (MACD) ChartAccolade Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Accolade Inc. The current adx is 65.20.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Accolade shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Accolade Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Accolade Inc. The current sar is 6.7471185.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Accolade Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Accolade Inc. The current rsi is 82.13. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Accolade Inc Daily Relative Strength Index (RSI) ChartAccolade Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Accolade Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Accolade price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Accolade Inc Daily Stochastic Oscillator ChartAccolade Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Accolade Inc. The current cci is 33.00.

Accolade Inc Daily Commodity Channel Index (CCI) ChartAccolade Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Accolade Inc. The current cmo is 59.40.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Accolade Inc Daily Chande Momentum Oscillator (CMO) ChartAccolade Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Accolade Inc. The current willr is -52.63157895.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Accolade is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Accolade Inc Daily Williams %R ChartAccolade Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Accolade Inc.

Accolade Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Accolade Inc. The current atr is 0.10131323.

Accolade Inc Daily Average True Range (ATR) ChartAccolade Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Accolade Inc. The current obv is -8,958,047.

Accolade Inc Daily On-Balance Volume (OBV) ChartAccolade Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Accolade Inc. The current mfi is 48.62.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Accolade Inc Daily Money Flow Index (MFI) ChartAccolade Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Accolade Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Accolade Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Accolade Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5082.132
Ma 20Greater thanMa 506.892
Ma 50Greater thanMa 1005.253
Ma 100Greater thanMa 2004.431
OpenGreater thanClose6.900
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Accolade with someone you think should read this too:
  • Are you bullish or bearish on Accolade? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Accolade? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Accolade Inc

I send you an email if I find something interesting about Accolade Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Accolade Inc.

Receive notifications about Accolade Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.